Company intelligence / Profile preview

Point72 Asset Management

Stamford, Connecticut, United States

Ownership: Private
Employees: ~2800
Development stage: Other

Overview

Point72 Asset Management is a leading global alternative investment firm driven by multi-strategy investing (discretionary long/short equity, quantitative, macro), not clinical development. It is not a drug developer and does not have pipeline clinical results.

Industry: Investors

Beyond the preview

Go deeper on Point72 Asset Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Point72 Asset Management.

Explore the full profile